<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">71624</article-id><article-id pub-id-type="doi">10.7554/eLife.71624</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Multi-omic rejuvenation of human cells by maturation phase transient reprogramming</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-244088"><name><surname>Gill</surname><given-names>Diljeet</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5725-2466</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244089"><name><surname>Parry</surname><given-names>Aled</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5192-3727</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244090"><name><surname>Santos</surname><given-names>Fátima</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3854-4084</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-203105"><name><surname>Okkenhaug</surname><given-names>Hanneke</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0669-4069</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271822"><name><surname>Todd</surname><given-names>Christopher D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244091"><name><surname>Hernando-Herraez</surname><given-names>Irene</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244092"><name><surname>Stubbs</surname><given-names>Thomas M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-244093"><name><surname>Milagre</surname><given-names>Inês</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3067"><name><surname>Reik</surname><given-names>Wolf</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0216-9881</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Epigenetics Programme</institution>, <institution>Babraham Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Imaging Facility</institution>, <institution>Babraham Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution>Chronomics Limited</institution>, <addr-line><named-content content-type="city">Norwich</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Laboratory for Epigenetic Mechanisms</institution>, <institution>Instituto Gulbenkian de Ciência</institution>, <addr-line><named-content content-type="city">Oeiras</named-content></addr-line>, <country>Portugal</country></aff><aff id="aff5"><institution>Altos Labs</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1421"><name><surname>Tyler</surname><given-names>Jessica K</given-names></name><role>Reviewing editor</role><aff><institution>Weill Cornell Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>imilagre@igc.gulbenkian.pt</email> (IM);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>wolf.reik@babraham.ac.uk</email> (WR);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>04</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e71624</elocation-id><history><date date-type="received"><day>24</day><month>06</month><year>2021</year></date><date date-type="accepted"><day>06</day><month>04</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Gill et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Gill et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-71624-v1.pdf"/><abstract><p>Ageing is the gradual decline in organismal fitness that occurs over time leading to tissue dysfunction and disease. At the cellular level, ageing is associated with reduced function, altered gene expression and a perturbed epigenome. Somatic cell reprogramming, the process of converting somatic cells to induced pluripotent stem cells (iPSCs), can reverse these age-associated changes. However, during iPSC reprogramming, somatic cell identity is lost, and can be difficult to reacquire as re-differentiated iPSCs often resemble foetal rather than mature adult cells. Recent work has demonstrated that the epigenome is already rejuvenated by the maturation phase of reprogramming, which suggests full iPSC reprogramming is not required to reverse ageing of somatic cells. Here we have developed the first 'maturation phase transient reprogramming' (MPTR) method, where reprogramming factors are expressed until this rejuvenation point followed by withdrawal of their induction. Using dermal fibroblasts from middle age donors, we found that cells temporarily lose and then reacquire their fibroblast identity during MPTR, possibly as a result of epigenetic memory at enhancers and/or persistent expression of some fibroblast genes. Excitingly, our method substantially rejuvenated multiple cellular attributes including the transcriptome, which was rejuvenated by around 30 years as measured by a novel transcriptome clock. The epigenome, including H3K9me3 histone methylation levels and the DNA methylation ageing clock, was rejuvenated to a similar extent. The magnitude of rejuvenation instigated by MTPR appears substantially greater than that achieved in previous transient reprogramming protocols. In addition, MPTR fibroblasts produced youthful levels of collagen proteins, and showed partial functional rejuvenation of their migration speed. Finally, our work suggests that more extensive reprogramming does not necessarily result in greater rejuvenation but instead that optimal time windows exist for rejuvenating the transcriptome and the epigenome. Overall, we demonstrate that it is possible to separate rejuvenation from complete pluripotency reprogramming, which should facilitate the discovery of novel anti-ageing genes and therapies.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gill</surname><given-names>Diljeet</given-names></name><name><surname>Santos</surname><given-names>Fátima</given-names></name><name><surname>Okkenhaug</surname><given-names>Hanneke</given-names></name><name><surname>Todd</surname><given-names>Christopher D</given-names></name><name><surname>Hernando-Herraez</surname><given-names>Irene</given-names></name><name><surname>Stubbs</surname><given-names>Thomas M</given-names></name><name><surname>Milagre</surname><given-names>Inês</given-names></name><name><surname>Reik</surname><given-names>Wolf</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Parry</surname><given-names>Aled</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Milky Way Research Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gill</surname><given-names>Diljeet</given-names></name><name><surname>Reik</surname><given-names>Wolf</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Wellcome Investigator award</institution></institution-wrap></funding-source><award-id>210754/Z/18/Z</award-id><principal-award-recipient><name><surname>Reik</surname><given-names>Wolf</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Thomas M Stubbs, is CEO and shareholder of Chronomics.</p></fn><fn fn-type="conflict" id="conf3"><p>Wolf Reik, is a consultant and shareholder of Cambridge Epigenetix. Is employed by Altos Labs..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>DNA methylation array and RNA-seq data are available on Gene Expression Omnibus under the accession number: GSE165180.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Gill D</collab><collab>Parry A</collab><collab>Santos F</collab><collab>Okkenhaug H</collab><collab>Todd CD</collab><collab>Hernando-Herraez I</collab><collab>Stubbs TM</collab><collab>Milagre I</collab><collab>Reik W</collab></person-group><year iso-8601-date="2022">2022</year><source>Multi-omic rejuvenation of human cells by maturation phase transient reprogramming</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE165180">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE165180</ext-link><comment>NCBI Gene Expression Omnibus, GSE165180</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Fleischer JG</collab><collab>et al</collab></person-group><year iso-8601-date="2018">2018</year><source>Predicting age from the transcriptome of human dermal fibroblasts</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113957">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113957</ext-link><comment>Gene Expression Omnibus, GSE113957</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Banovich NE</collab><collab>et al</collab></person-group><year iso-8601-date="2018">2018</year><source>Impact of regulatory variation across human iPSCs and differentiated cells [RNA-seq]</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE107654">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE107654</ext-link><comment>Gene Expression Omnibus, GSE107654</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ohnuki M</collab><collab>et al</collab></person-group><year iso-8601-date="2014">2014</year><source>Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54848">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54848</ext-link><comment>Gene Expression Omnibus, GSE54848</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Banovich NE</collab><collab>et al</collab></person-group><year iso-8601-date="2018">2018</year><source>Impact of regulatory variation across human iPSCs and differentiated cells [methylation]</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE110544">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE110544</ext-link><comment>Gene Expression Omnibus, GSE110544</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Horvath S</collab><collab>et al</collab></person-group><year iso-8601-date="2018">2018</year><source>Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies.</source><ext-link ext-link-type="uri" xlink:href="Received from author.">Received from author.</ext-link><comment>Received from author</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-71624-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>